Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,629 | 26,762 | 28,849 | 44,406 | 61,580 |
| Marketable Securities | 114,108 | 147,375 | 162,729 | 167,296 | 165,336 |
| Receivables | 6 | 179 | 225 | 78 | 116 |
| TOTAL | $148,389 | $178,500 | $195,958 | $215,742 | $231,160 |
| Non-Current Assets | |||||
| PPE Net | 76,597 | 64,351 | 62,599 | 61,247 | 57,321 |
| Intangibles | 40,000 | 50,000 | 50,000 | 50,000 | 50,000 |
| Other Non-Current Assets | 1,986 | 1,974 | 2,168 | 2,360 | 2,620 |
| TOTAL | $118,583 | $116,325 | $114,767 | $113,607 | $109,941 |
| Total Assets | $266,972 | $294,825 | $310,725 | $329,349 | $341,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,511 | 13,148 | 7,048 | 8,734 | 10,343 |
| Accrued Expenses | 7,489 | 6,711 | 5,037 | 2,912 | 5,478 |
| TOTAL | $28,679 | $20,618 | $12,986 | $12,679 | $18,230 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,569 | 1,583 | 1,597 | 1,611 | 1,625 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,400 |
| Other Non-Current Liabilities | 1,391 | 1,313 | 1,355 | 1,319 | 1,483 |
| TOTAL | $31,262 | $31,991 | $32,047 | $32,025 | $32,203 |
| Total Liabilities | $59,941 | $52,609 | $45,033 | $44,704 | $50,433 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,933 | 74,338 | 74,263 | 74,228 | 74,052 |
| Common Shares | 74 | 74 | 74 | 73 | 70 |
| Retained earnings | -334,840 | -297,350 | -271,381 | -249,896 | -231,719 |
| Other shareholders' equity | 110 | 114 | 3 | 19 | -51 |
| TOTAL | $207,031 | $242,216 | $265,692 | $284,645 | $290,668 |
| Total Liabilities And Equity | $266,972 | $294,825 | $310,725 | $329,349 | $341,101 |